Business ❯Pharmaceuticals ❯Biotechnology

mRNA Technology

CureVac mRNA Technology GSK mRNA Technology Moderna

Moderna to Cut $1.1 Billion in R&D Spending as Vaccine Sales Decline

GSK Acquires CureVac's mRNA Vaccines for COVID-19, Flu